{"id":"desmopressin-injectable-solution","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyponatremia"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Facial flushing"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Desmopressin mimics the action of endogenous antidiuretic hormone (ADH/vasopressin) by selectively activating V2 receptors in the renal collecting ducts, promoting aquaporin-2 water channel insertion and increasing water reabsorption. This mechanism reduces polyuria and increases urine osmolality, making it effective for conditions characterized by insufficient endogenous ADH or impaired renal response to ADH.","oneSentence":"Desmopressin is a synthetic vasopressin analog that binds to V2 receptors on kidney collecting duct cells to increase water reabsorption and reduce urine output.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:09:06.135Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Central diabetes insipidus"},{"name":"Nocturnal enuresis"},{"name":"Von Willebrand disease"},{"name":"Hemophilia A"}]},"trialDetails":[{"nctId":"NCT04569591","phase":"NA","title":"DDAVP for Pituitary Adenoma","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2026-03-09","conditions":"Cushing's Disease, Pituitary Adenoma","enrollment":22},{"nctId":"NCT06337838","phase":"PHASE3","title":"Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-06-09","conditions":"Chronic Kidney Diseases, Acute Kidney Injury, Bleeding","enrollment":100},{"nctId":"NCT07292753","phase":"NA","title":"Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-12-15","conditions":"Nocturnal Enuresis, Vitamin D Deficiency","enrollment":90},{"nctId":"NCT06771128","phase":"NA","title":"Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2024-11-01","conditions":"Nocturnal Enuresis in Children, Desmopressin, Monosymptomatic Nocturnal Enuresis","enrollment":398},{"nctId":"NCT06635629","phase":"PHASE2","title":"Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2024-12-12","conditions":"Cushing Syndrome","enrollment":140},{"nctId":"NCT07199894","phase":"PHASE3","title":"Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2024-12-01","conditions":"Nocturnal Enuresis in Children","enrollment":120},{"nctId":"NCT07179991","phase":"","title":"DDAVP Effect by TEG6 in Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2025-10-01","conditions":"Intraoperative Bleeding","enrollment":100},{"nctId":"NCT06622187","phase":"PHASE4","title":"Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies","status":"ENROLLING_BY_INVITATION","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2024-08-14","conditions":"Bleeding, Transplant, Kidney, Desmopressin","enrollment":96},{"nctId":"NCT07028645","phase":"","title":"Uroflowmetry and Nocturnal Enuresis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Furkan Adem Canbaz","startDate":"2022-08-20","conditions":"Enuresis, Nocturnal","enrollment":100},{"nctId":"NCT07012837","phase":"PHASE3","title":"Transfusion Reduction in High-Bleeding-Risk Cardiac Surgery With Desmopressin","status":"NOT_YET_RECRUITING","sponsor":"Imam Abdulrahman Bin Faisal University","startDate":"2025-07","conditions":"Adult Patients Undergoing Cardiac Surgery, High Bleeding Risks, Planned Elective Cardiac Surgery Using CPB","enrollment":112},{"nctId":"NCT06962202","phase":"","title":"Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2022-08-15","conditions":"Cushing Syndrome","enrollment":100},{"nctId":"NCT05467033","phase":"PHASE3","title":"Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin","status":"RECRUITING","sponsor":"Medical University of Bialystok","startDate":"2022-09-01","conditions":"Kidney Biopsy","enrollment":424},{"nctId":"NCT06277336","phase":"NA","title":"Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIAD","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-03-01","conditions":"SIAD - Syndrome of Inappropriate Antidiuresis, Hyponatremia","enrollment":15},{"nctId":"NCT06883851","phase":"NA","title":"Effectiveness of Pelvic Floor Muscle Rehabilitation Combined With Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis","status":"RECRUITING","sponsor":"Bahçeşehir University","startDate":"2025-03-11","conditions":"Primary Nocturnal Enuresis, Nocturnal Enuresis in Children","enrollment":40},{"nctId":"NCT03847207","phase":"PHASE1","title":"A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310","status":"COMPLETED","sponsor":"Nxera Pharma UK Limited","startDate":"2019-01-23","conditions":"Healthy","enrollment":42},{"nctId":"NCT06772584","phase":"NA","title":"Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2024-01-01","conditions":"Enuresis, Nocturnal","enrollment":90},{"nctId":"NCT04329975","phase":"","title":"Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2020-05-19","conditions":"Nocturia Due to Nocturnal Polyuria","enrollment":1087},{"nctId":"NCT05507476","phase":"NA","title":"Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2022-09-01","conditions":"Anesthesia","enrollment":52},{"nctId":"NCT05517590","phase":"NA","title":"Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.","status":"COMPLETED","sponsor":"Acibadem University","startDate":"2022-09-01","conditions":"Leiomyoma, Uterine, Intraoperative Blood Loss","enrollment":102},{"nctId":"NCT04420585","phase":"PHASE4","title":"Desmopressin for Bedwetting in Children With SCD","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2020-07-07","conditions":"Nocturnal Enuresis, Anemia, Sickle Cell","enrollment":8},{"nctId":"NCT06285006","phase":"NA","title":"Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis","status":"RECRUITING","sponsor":"Al-Azhar University","startDate":"2024-02-23","conditions":"Nocturnal Enuresis","enrollment":50},{"nctId":"NCT04103034","phase":"PHASE1","title":"A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers","status":"COMPLETED","sponsor":"Band Therapeutics","startDate":"2019-10-07","conditions":"Cerebrovascular Stroke, Large-Artery Atherosclerosis (Embolus/Thrombosis), Intracranial Arteriosclerosis","enrollment":112},{"nctId":"NCT06255366","phase":"PHASE4","title":"Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion","status":"NOT_YET_RECRUITING","sponsor":"Chengdu University of Traditional Chinese Medicine","startDate":"2024-03-28","conditions":"Lumbar Spondylolisthesis, Arthrosis; Spine","enrollment":126},{"nctId":"NCT06185361","phase":"NA","title":"Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.","status":"UNKNOWN","sponsor":"Fayoum University Hospital","startDate":"2022-12-01","conditions":"Nocturnal Enuresis, Enuresis, Enuresis, Nocturnal","enrollment":60},{"nctId":"NCT06020456","phase":"","title":"Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A","status":"COMPLETED","sponsor":"Groupe Maladies hémorragiques de Bretagne","startDate":"2022-01-01","conditions":"Carrier of Hemophilia A, Desmopressin, Factor VIII Deficiency","enrollment":361},{"nctId":"NCT05399173","phase":"NA","title":"Effect of Laser Acupuncture for Treating Monosymptomatic Nocturnal Enuresis in Adolescent Females","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2022-06-02","conditions":"Non-Specific Urethritis","enrollment":60},{"nctId":"NCT01982760","phase":"PHASE2","title":"DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty","status":"TERMINATED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2013-12","conditions":"Postoperative Ecchymosis","enrollment":14},{"nctId":"NCT05617664","phase":"NA","title":"Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis","status":"UNKNOWN","sponsor":"Benha University","startDate":"2022-11-23","conditions":"Nocturnal Enuresis","enrollment":150},{"nctId":"NCT03389412","phase":"PHASE4","title":"The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2017-10-01","conditions":"Enuresis, Nocturnal","enrollment":324},{"nctId":"NCT05945420","phase":"PHASE4","title":"Adding Desmopressin to Tamsulosin for Treatment of BPH","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2023-07-20","conditions":"Nocturnal Polyurea in Patients With BPH","enrollment":160},{"nctId":"NCT01439997","phase":"PHASE4","title":"Desmopressin Melt Therapy in Nocturnal Polyuria Patients: Pharmacodynamic Study","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2012-03-26","conditions":"Nocturia","enrollment":5},{"nctId":"NCT01645475","phase":"PHASE4","title":"Desmopressin Melt: Impact on Sleep and Daytime Functioning","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2011-04","conditions":"Monosymptomatic Nocturnal Enuresis","enrollment":30},{"nctId":"NCT05628558","phase":"","title":"Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A","status":"UNKNOWN","sponsor":"Groupe Maladies hémorragiques de Bretagne","startDate":"2020-07-01","conditions":"Hemophilia A, Mild, Desmopressin, Factor VIII","enrollment":800},{"nctId":"NCT03696121","phase":"PHASE2","title":"Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2019-04-01","conditions":"Stroke, Acute","enrollment":54},{"nctId":"NCT05430048","phase":"PHASE2","title":"Nasal Desmopressin Versus Oral Bisoprolol for Controlling Bleeding During Endoscopic Sinus Surgery","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2022-07-01","conditions":"Bleeding","enrollment":100},{"nctId":"NCT05414279","phase":"NA","title":"Validation of Capillary Serum Sodium Levels","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2021-04-30","conditions":"Nocturia","enrollment":100},{"nctId":"NCT02636387","phase":"","title":"Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2015-08-26","conditions":"Nocturnal Enuresis, Anemia, Sickle Cell","enrollment":14},{"nctId":"NCT02933411","phase":"","title":"Low VW Activity in Adolescent HMB","status":"UNKNOWN","sponsor":"Baylor College of Medicine","startDate":"2017-01-05","conditions":"Von Willebrand Factor Deficiency","enrollment":120},{"nctId":"NCT03201419","phase":"PHASE2","title":"A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2017-07-27","conditions":"Nocturia","enrollment":302},{"nctId":"NCT02621736","phase":"","title":"Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2016-01-01","conditions":"Nocturnal Enuresis","enrollment":28},{"nctId":"NCT03733873","phase":"NA","title":"Study on Chinese and Western Medicine in MNE Children","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2018-09-01","conditions":"Monosymptomatic Nocturnal Enuresis","enrollment":400},{"nctId":"NCT03089073","phase":"","title":"Study of Minirin Melt® in Adult Patients With Nocturia","status":"TERMINATED","sponsor":"Ferring Pharmaceuticals","startDate":"2015-07-13","conditions":"Nocturia","enrollment":835},{"nctId":"NCT00981682","phase":"PHASE3","title":"Long Term Safety Assessment of SER120 in Patients With Nocturia","status":"COMPLETED","sponsor":"Serenity Pharmaceuticals, Inc.","startDate":"2009-08","conditions":"Nocturia","enrollment":376},{"nctId":"NCT04586790","phase":"PHASE2","title":"the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock","status":"UNKNOWN","sponsor":"Ahmed talaat ahmed aly","startDate":"2020-10-15","conditions":"Spinal Shock","enrollment":90},{"nctId":"NCT04545931","phase":"PHASE4","title":"Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-03-15","conditions":"Primary Monosymptomatic Nocturnal Enuresis","enrollment":80},{"nctId":"NCT04113005","phase":"EARLY_PHASE1","title":"Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer","status":"UNKNOWN","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2019-10-01","conditions":"Castrate Resistance Prostate Cancer","enrollment":10},{"nctId":"NCT02905682","phase":"PHASE3","title":"Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2016-09","conditions":"Nocturia","enrollment":190},{"nctId":"NCT02904759","phase":"PHASE3","title":"Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2016-09","conditions":"Nocturia","enrollment":342},{"nctId":"NCT03676361","phase":"PHASE4","title":"To Evaluate the Renal Tubular Function Pre and Post Nephrectomy in Living Donors","status":"WITHDRAWN","sponsor":"University of Kansas Medical Center","startDate":"2018-08-29","conditions":"Kidney Damage","enrollment":""},{"nctId":"NCT01036841","phase":"PHASE4","title":"Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2009-12","conditions":"Enuresis, Polyuria","enrollment":24},{"nctId":"NCT02584231","phase":"PHASE4","title":"Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population","status":"COMPLETED","sponsor":"University Ghent","startDate":"2015-09-09","conditions":"Monosymptomatic Nocturnal Enuresis","enrollment":25},{"nctId":"NCT03051009","phase":"PHASE3","title":"Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2017-01-11","conditions":"Nocturia","enrollment":503},{"nctId":"NCT01729819","phase":"PHASE2","title":"Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2013-01","conditions":"Overactive Bladder","enrollment":106},{"nctId":"NCT02506023","phase":"PHASE1","title":"Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-07","conditions":"Hemophilia A","enrollment":2},{"nctId":"NCT03510975","phase":"PHASE4","title":"A New Check-list Method for Nocturnal Enuresis","status":"COMPLETED","sponsor":"Ankara Training and Research Hospital","startDate":"2015-01-01","conditions":"Nocturnal Enuresis","enrollment":75},{"nctId":"NCT01218074","phase":"NA","title":"Platelets Antiaggregation Control Enhancement (PACE) Study","status":"TERMINATED","sponsor":"Cardiochirurgia E.H.","startDate":"2010-12","conditions":"Bleeding, Blood Transfusion","enrollment":200},{"nctId":"NCT03343418","phase":"PHASE4","title":"Effects of Prophylactic Desmopressin on Blood Coagulation Parameters in Heart Valve Surgery","status":"UNKNOWN","sponsor":"Instituto do Coracao","startDate":"2015-02","conditions":"C.Surgical Procedure; Cardiac, Blood Coagulation Disorders","enrollment":108},{"nctId":"NCT00223717","phase":"PHASE1","title":"Treatment of Supine Hypertension in Autonomic Failure","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2001-01","conditions":"Hypertension","enrollment":152},{"nctId":"NCT01623206","phase":"PHASE2","title":"Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding","status":"COMPLETED","sponsor":"Laboratorio Elea Phoenix S.A.","startDate":"2013-04","conditions":"Colorectal Cancer, Rectal Bleeding","enrollment":30},{"nctId":"NCT01552343","phase":"PHASE3","title":"Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2012-03","conditions":"Nocturia","enrollment":56},{"nctId":"NCT02125188","phase":"PHASE4","title":"Effects of Desmopressin on Blood Loss and the Quality of the Surgical Field During Endoscopic Sinus Surgery","status":"COMPLETED","sponsor":"Tao Zhang","startDate":"2014-01","conditions":"Patients Undergoing Endoscopic Sinus Surgery","enrollment":60},{"nctId":"NCT02368730","phase":"","title":"Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2015-06","conditions":"Platelet Dysfunction","enrollment":23},{"nctId":"NCT01994330","phase":"PHASE4","title":"Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2009-06","conditions":"Acquired Von Willebrand Disease Secondary to Severe Aortic Stenosis, Heye´s Syndrome, Severe Aortic Stenosis","enrollment":13},{"nctId":"NCT02262936","phase":"PHASE2, PHASE3","title":"Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older","status":"TERMINATED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2015-07","conditions":"Nocturia","enrollment":4},{"nctId":"NCT02937896","phase":"NA","title":"Intranasal Desmopressin vs IV Ketorolac in Renal Colic Pain Control","status":"COMPLETED","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2015-01","conditions":"Renal Colic","enrollment":40},{"nctId":"NCT02729766","phase":"PHASE2, PHASE3","title":"Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2016-03","conditions":"Inappropriate ADH Syndrome","enrollment":15},{"nctId":"NCT02084797","phase":"NA","title":"V2 Receptor Effects on Fluid Regulation and Performance","status":"COMPLETED","sponsor":"Oakland University","startDate":"2011-06","conditions":"Electrolyte Imbalance, Hyponatremia, Hypernatremia","enrollment":10},{"nctId":"NCT00615836","phase":"PHASE3","title":"An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving (\"Melt\") Formulation of Desmopressin for the Treatment of Nocturia in Adults","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2007-12","conditions":"Nocturia","enrollment":554},{"nctId":"NCT00477490","phase":"PHASE3","title":"Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2007-05","conditions":"Nocturia","enrollment":799},{"nctId":"NCT00337766","phase":"PHASE4","title":"Desmopressin in Cardiac Surgery","status":"COMPLETED","sponsor":"Università Vita-Salute San Raffaele","startDate":"2006-06","conditions":"Hemorrhage, Blood Loss, Surgical, Postoperative Hemorrhage","enrollment":""},{"nctId":"NCT01262456","phase":"PHASE3","title":"Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2011-02","conditions":"Nocturia","enrollment":395},{"nctId":"NCT01223937","phase":"PHASE3","title":"Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-11","conditions":"Nocturia","enrollment":268},{"nctId":"NCT02538302","phase":"PHASE3","title":"Minirin Versus Oxybutynin for Nocturnal Enuresis in Children","status":"COMPLETED","sponsor":"Hormozgan University of Medical Sciences","startDate":"2013-07","conditions":"Nocturnal Enuresis","enrollment":66},{"nctId":"NCT01606072","phase":"PHASE2","title":"Perioperative Use of Desmopressin (DDAVP) in Breast Cancer","status":"COMPLETED","sponsor":"Laboratorio Elea Phoenix S.A.","startDate":"2011-11","conditions":"Breast Cancer","enrollment":21},{"nctId":"NCT01779466","phase":"PHASE2","title":"Daytime Impact Sleep Study","status":"TERMINATED","sponsor":"Ferring Pharmaceuticals","startDate":"2013-04","conditions":"Nocturia","enrollment":5},{"nctId":"NCT00885924","phase":"PHASE4","title":"Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery","status":"TERMINATED","sponsor":"St. Olavs Hospital","startDate":"2009-03","conditions":"Hemorrhage, Postoperative Blood Loss","enrollment":17},{"nctId":"NCT01530451","phase":"PHASE3","title":"Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients","status":"TERMINATED","sponsor":"Chinese University of Hong Kong","startDate":"2012-03","conditions":"Nocturia, Obstructive Sleep Apnoea","enrollment":9},{"nctId":"NCT02068560","phase":"NA","title":"The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2012-05","conditions":"Gender Difference in V2 Receptor Function in Response to dDAVP Infusion, Nocturia, Nocturnal Enuresis","enrollment":64},{"nctId":"NCT01435083","phase":"PHASE4","title":"Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2011-11","conditions":"Nocturnal Polyuria","enrollment":50},{"nctId":"NCT01576900","phase":"","title":"The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2012-04","conditions":"Nocturia","enrollment":124},{"nctId":"NCT00961532","phase":"PHASE2","title":"Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2010-12","conditions":"Intracerebral Hemorrhage","enrollment":14},{"nctId":"NCT02084342","phase":"NA","title":"Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery","status":"UNKNOWN","sponsor":"Liu Weifeng","startDate":"2013-12","conditions":"Idiopathic Scoliosis","enrollment":60},{"nctId":"NCT01382134","phase":"NA","title":"Effect of Aspirin, Hemodilution and Desmopressin on Platelet Dysfunction","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2011-07","conditions":"Platelet Dysfunction, Hemodilution, Mild Hypothermia","enrollment":60},{"nctId":"NCT01684800","phase":"PHASE2","title":"Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2012-09","conditions":"Nocturia","enrollment":178},{"nctId":"NCT01694498","phase":"PHASE2","title":"Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2012-09","conditions":"Nocturia","enrollment":183},{"nctId":"NCT01368913","phase":"","title":"MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2011-06","conditions":"Nocturnal Enuresis","enrollment":138},{"nctId":"NCT01841515","phase":"PHASE1","title":"Effect of Desmopressin on Platelet Function in CKD Patients on Antiplatelet Drug","status":"COMPLETED","sponsor":"University of Ulsan","startDate":"2012-08","conditions":"Bleeding, Tachycardia, Dyspnea","enrollment":25},{"nctId":"NCT01742689","phase":"PHASE3","title":"Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic","status":"UNKNOWN","sponsor":"Tehran University of Medical Sciences","startDate":"2012-03","conditions":"Renal Colic, Pain","enrollment":88},{"nctId":"NCT01280188","phase":"PHASE3","title":"A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2011-01","conditions":"Central Diabetes Insipidus","enrollment":20},{"nctId":"NCT01184859","phase":"PHASE2","title":"Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-07","conditions":"Nocturia","enrollment":116},{"nctId":"NCT01582542","phase":"PHASE4","title":"Desmopressin for Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Bladder Reconstruction","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2012-04","conditions":"Nocturnal Enuresis","enrollment":50},{"nctId":"NCT01534117","phase":"NA","title":"Platelet Function Analysis in Head Trauma: ASA/Plavix","status":"COMPLETED","sponsor":"Chang, Steve S., M.D.","startDate":"2009-10","conditions":"Head Injury Trauma Blunt","enrollment":97},{"nctId":"NCT01078753","phase":"PHASE3","title":"Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-01","conditions":"Nocturnal Enuresis","enrollment":89},{"nctId":"NCT00230594","phase":"PHASE3","title":"Desmopressin Response in the Young","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2004-07","conditions":"Primary Nocturnal Enuresis","enrollment":132},{"nctId":"NCT00245479","phase":"PHASE4","title":"A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2002-04","conditions":"Nocturnal Enuresis","enrollment":802},{"nctId":"NCT00902265","phase":"","title":"Efficacy and Safety of Desmopressin (Nocturin®) 0.1 mg Tablets in Treatment of Nocturia in Participants With Benign Prostate Syndrome (BPS)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2009-02","conditions":"Nocturia Associated With Nocturnal Polyuria","enrollment":138},{"nctId":"NCT00806468","phase":"PHASE4","title":"Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease","status":"TERMINATED","sponsor":"Johannes Gutenberg University Mainz","startDate":"2009-02","conditions":"Parkinson Disease","enrollment":1},{"nctId":"NCT00835211","phase":"PHASE1","title":"Desmopressin Acetate 0.2 mg Tablets, Fasting","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-07","conditions":"Healthy","enrollment":48},{"nctId":"NCT00902655","phase":"PHASE4","title":"Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2004-04","conditions":"Nocturia","enrollment":103},{"nctId":"NCT00902057","phase":"PHASE4","title":"Desmopressin for Bleeding Related to Low Body Temperature","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2009-06","conditions":"Hypothermia Induced Impairment of Primary Haemostasis","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DDAVP"],"phase":"phase_3","status":"active","brandName":"Desmopressin Injectable Solution","genericName":"Desmopressin Injectable Solution","companyName":"Hamilton Health Sciences Corporation","companyId":"hamilton-health-sciences-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Desmopressin is a synthetic vasopressin analog that binds to V2 receptors on kidney collecting duct cells to increase water reabsorption and reduce urine output. Used for Central diabetes insipidus, Nocturnal enuresis, Von Willebrand disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}